DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Fukuhara T, Hyogo H, Ochi H. et al.
Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver
disease with type 2 diabetes mellitus.
Hepatogastroenterology 2014;
61: 323-328
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.